Empresa Onconova Therapeutics Inc Nasdaq
Acciones
US68232V3069
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Oncology Therapeutics
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -.--% |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mark Guerin
DFI | Director of Finance/CFO | 55 | 01/09/13 |
Meena Arora
CTO | Chief Tech/Sci/R&D Officer | - | 24/10/23 |
Victor Moyo
CTO | Chief Tech/Sci/R&D Officer | - | 24/10/23 |
Matthew Parris
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
James Marino
BRD | Director/Board Member | 74 | 01/07/15 |
Jack Stover
BRD | Director/Board Member | 69 | 23/05/16 |
Mary Shoemaker
BRD | Director/Board Member | 63 | 01/04/20 |
Trafford Clarke
BRD | Director/Board Member | 66 | 19/12/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 25 301 009 | 21 600 723 ( 85,37 %) | 0 | 85,37 % |
Información de la empresa
![Dirección Onconova Therapeutics Inc](https://cdn.zonebourse.com/static/address/27878998.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+38,65 % | 39,36 mil M | |
-8,62 % | 38,52 mil M | |
+26,95 % | 30,74 mil M | |
+10,74 % | 25,92 mil M | |
-13,50 % | 26,03 mil M | |
+44,87 % | 14,13 mil M | |
+34,36 % | 12,73 mil M | |
-7,14 % | 11,29 mil M | |
-12,61 % | 10,64 mil M |